AG-13958

https://www.abfrontier.com/web/image/product.template/81042/image_1920?unique=6fdf00c
AG-13958 (AG-013958), a potent VEGFR tyrosine kinase inhibitor, is used for treatment of choroidal neovascularization associated with age-related macular degeneration (AMD).

2,794.80 2794.8 USD 2,794.80

2,794.80 €

Not Available For Sale

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days